Funder
Key Technologies Research and Development Program
Subject
Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy
Reference37 articles.
1. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development;Spagnolo;Pharmacol. Ther.,2021
2. Research progress in the molecular mechanisms, therapeutic targets, and drug development of idiopathic pulmonary fibrosis;Ma;Front. Pharmacol.,2022
3. Complex involvement of the extracellular matrix, immune effect, and lipid metabolism in the development of idiopathic pulmonary fibrosis;Qian;Front. Mol. Biosci.,2021
4. Idiopathic pulmonary fibrosis;Richeldi;Lancet,2017
5. Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: A systematic review and meta-analysis;Finnerty;BMC Pulm. Med.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献